On the metabolism of 16-alpha-hydroxy-C21-steroids. 3. Evidence for high rates of production of 16-alpha-hydroxyprogesterone and 16-alpha-hydroxypregnenolone in the salt-losing form of congenital adrenal hyperplasia.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy / Q000378:metabolism*; D000328:Adult; D002648:Child; D002845:Chromatography; D005260:Female; D006801:Humans; D008297:Male; D010783:Photometry; D011278:Pregnanes / Q000096:biosynthesis*; D011279:Pregnanetriol / Q000652:urine; D014221:Triamcinolone / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D011278:Pregnanes; D014221:Triamcinolone; D011279:Pregnanetriol